c-KIT gene mutation detection liquid-phase chip
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SUREXAM BIO TECH
- Publication Date
- 2011-03-09
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of molecular biology, relates to medicine and biotechnology, in particular to a c-KIT gene mutation detection liquid phase chip. Background technique
[0002] Gastrointestinal stromal tumor (GIST) is a special tumor originating from the gastrointestinal tract. In recent years, with the in-depth research on the molecular pathology of GIST and the application of targeted drugs, GIST has attracted more and more attention. Surgical resection is still the only curative treatment for GIST, but the recurrence rate is extremely high. The molecular targeted drug imatinib mesylate (Gleevec) has achieved very good curative effect in the treatment of GIST and is the drug of choice for GIST patients today.
[0003] The mechanism of action of imatinib is to inhibit the tyrosine kinase of platelet-derived growth factor (PDGFR) receptor and c-KIT receptor, thereby inhibiting the cell behavior mediated by PDGFR and c-KIT, and then i...